Case report: First report on ambisome-associated allergic reaction in two Sudanese leishmaniasis patients

American Journal of Tropical Medicine and Hygiene

Volumn 85, Issue 4, 2011, Pages 644-645

  Mukhtar, Maowia ^a   Aboud, Mona ^b   Kheir, Musa ^c   Bakhiet, Sahar ^a   Abdullah, Nazik ^c   Ali, Ahmed ^c   Hassan, Nadia ^c   Elamin, Elwaleed ^d   Elagib, Atif ^e  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b Umdurman Tropical Diseases Hospital   (Sudan)

^c UNIVERSITY OF KHARTOUM   (Sudan)

^d Faculty of Medical Laboratory Sciences   (Sudan)

^e TROPICAL MEDICINE RESEARCH INSTITUTE   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIHISTAMINIC AGENT; HYDROCORTISONE; STIBOGLUCONATE SODIUM; AMPHOTERICIN B;

ADULT; ALLERGIC REACTION; ANAMNESIS; ARTICLE; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; HUMAN TISSUE; MALE; MUCOSAL LEISHMANIASIS; POST KALA AZAR DERMAL LEISHMANIASIS; SKIN LEISHMANIASIS; SUDAN; VISCERAL LEISHMANIASIS; HYPERSENSITIVITY; LEISHMANIASIS; MIDDLE AGED;

LEISHMANIA DONOVANI; NASO HEXACANTHUS;

ADULT; AMPHOTERICIN B; HUMANS; HYPERSENSITIVITY; LEISHMANIASIS; MALE; MIDDLE AGED; SUDAN;

EID: 80053895949     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.10-0511     Document Type: Article

References (8)

1. Elhassan AM, Zijlstra EE, 2001. Leishmaniasis in Sudan: mucosal leishmaniasis. Trans R Soc Trop Med Hyg 95 (Suppl 1): S19-S26.
2. Zijlstra EE, el-Hassan AM, 2001. Leishmaniasis in Sudan. Post kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg 95 (Suppl 1): S59-S76.
3. Berman J, 2003. Current treatment approaches to leishmaniasis . Curr Opin Infect Dis 16: 397-401. (Pubitemid 37267258)
4. Malani PN, Depestel DD, Riddell J, Bickley S, Klein LR, Kauffman CA, 2005. Experience with community-based amphotericin B infusion therapy. Pharmacotherapy 25: 690-697. (Pubitemid 40604885)
5. Collazos J, Marteniz E, Mayo J, Ibbara S, 2001. Pulmonary reactions during treatment with amphotericin B: review of published cases and guidelines for management. Clin Infect Dis 33: E75-E82.
6. Moen MD, Lyseng-Williamson KA, Scott LJ, 2009. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Drugs 69: 361-392.
7. Bates CM, Carey PB, Hind CR, 1995. Anaphylaxis due to liposomal amphotericin (AmBisome). Genitourin Med 71: 414.
8. Laing RB, Milne LJ, Leen CL, Malcolm GP, Steers AJ, 1994. Anaphylactic reactions to liposomal amphotericin. Lancet 344: 682.